Abstract
To confirm discrepant SARS-CoV-2-IgG results in four standard assays we applied for the first time a prototype of a coronavirus IgG-line-blot which employs antigens from seasonal coronaviruses, SARS-1 and SARS-CoV-2 combined with avidity testing as a confirmatory tool in a follow-up of five cases including pre-pandemic samples.
Keywords: COVID-19; Line blot; Nucleocapsid; SARS-CoV-2; Serology; Specific antibodies; Spike protein.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, serology, Spike protein, nucleocapsid, specific antibodies, Line blot, 【초록키워드】 coronavirus, spike, serology, Spike protein, Antigen, Protein, nucleocapsid, antigens, Follow-up, seasonal coronaviruses, specific antibodies, prototype, Specific, SARS-1, LINE, FIVE, applied, 【제목키워드】 Patient, Follow-up, SARS-CoV-2 IgG, observation, IgG test, FIVE,
【저자키워드】 COVID-19, SARS-CoV-2, serology, Spike protein, nucleocapsid, specific antibodies, Line blot, 【초록키워드】 coronavirus, spike, serology, Spike protein, Antigen, Protein, nucleocapsid, antigens, Follow-up, seasonal coronaviruses, specific antibodies, prototype, Specific, SARS-1, LINE, FIVE, applied, 【제목키워드】 Patient, Follow-up, SARS-CoV-2 IgG, observation, IgG test, FIVE,
{{{ 추상적인 }}}
SARS-CoV-2-IgG 결과가 4가지 표준 분석에서 일치하지 않는지 확인하기 위해 처음으로 계절성 코로나바이러스, SARS-1 및 SARS-CoV-2의 항원을 결합한 코로나바이러스 IgG-line-blot의 프로토타입을 적용했습니다. 팬데믹 이전 샘플을 포함한 5건의 후속 조치에서 확인 도구로 테스트.
{{ 키워드: }} 코로나19; 라인 오점; 뉴클레오캡시드; 사스 코로나바이러스 2; 혈청학; 특정 항체; 스파이크 단백질.